Profile data is unavailable for this security.
About the company
COSMO BIO COMPANY,LIMITED is a Japan-based company mainly engaged in purchase and wholesale of research reagents, equipment, consignment services and clinical test drugs related to life science. Research reagents business imports majority research reagents from United States and Europe, which are prioritized in life science related research. In the equipment business, the Company handles equipment specialized in life science research, purchases goods from a wide range of domestic and overseas, and mainly sells it to the domestic market. The equipment includes ultrasonic cell disruption equipment, bioimaging related equipment and research consumables. The Company provides clinical test drugs mainly used at hospitals and testing centers.
- Revenue in JPY (TTM)10.51bn
- Net income in JPY243.00m
- Incorporated1983
- Employees174.00
- LocationCosmo Bio Co LtdToyo-Ekimae Bldg., 2-2-20, ToyoKOTO-KU 135-0016JapanJPN
- Phone+81 356329600
- Fax+81 356329613
- Websitehttps://www.cosmobio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Delta-Fly Pharma Inc | 0.00 | -1.65bn | 2.70bn | 13.00 | -- | 7.20 | -- | -- | -162.56 | -162.56 | 0.00 | 30.84 | 0.00 | -- | -- | 0.00 | -352.25 | -88.06 | -490.58 | -97.02 | -- | -- | -- | -1,051.54 | -- | -4,172.58 | 0.00 | -- | -- | -- | -20.41 | -- | -61.24 | -- |
| Perseus Proteomics Inc | 121.95m | -788.76m | 3.48bn | 32.00 | -- | 3.31 | -- | 28.54 | -53.50 | -53.50 | 8.27 | 71.39 | 0.0668 | 1.85 | 10.22 | 3,810,875.00 | -43.18 | -38.61 | -46.14 | -40.75 | 87.27 | 90.16 | -646.80 | -837.30 | 14.76 | -- | 0.00 | -- | 19.89 | 7.02 | 18.08 | -- | 95.88 | -- |
| Muromachi Chemicals Inc | 7.37bn | 364.59m | 4.56bn | 203.00 | 12.43 | 1.69 | 8.44 | 0.6191 | 89.59 | 89.59 | 1,819.39 | 658.42 | 1.23 | 3.81 | 5.84 | 36,304,700.00 | 6.09 | 5.99 | 8.66 | 10.36 | 29.85 | 29.90 | 4.95 | 4.89 | 1.76 | 18.37 | 0.4769 | 26.50 | 4.46 | 4.73 | -26.93 | 50.19 | 32.64 | -- |
| Symbio Pharmaceuticals Ltd | 1.31bn | -4.78bn | 5.57bn | 108.00 | -- | 4.07 | -- | 4.26 | -95.49 | -95.49 | 26.04 | 21.39 | 0.296 | 1.37 | 3.83 | -- | -108.11 | -19.84 | -140.91 | -24.15 | 72.45 | 74.71 | -365.25 | -26.66 | 2.74 | -44.43 | 0.6092 | -- | -46.69 | -15.23 | -24.59 | -- | -11.15 | -- |
| Kohjin Bio Co Ltd | 5.20bn | 719.61m | 6.27bn | 167.00 | 8.72 | 1.08 | 5.71 | 1.21 | 140.79 | 140.79 | 1,017.95 | 1,137.25 | 0.5995 | 3.69 | 5.53 | 31,156,770.00 | 8.29 | -- | 11.44 | -- | 44.58 | -- | 13.83 | -- | 1.61 | -- | 0.2512 | -- | 9.14 | -- | 106.44 | -- | -- | -- |
| MEDRx Co Ltd | 121.55m | -1.26bn | 6.71bn | 22.00 | -- | 3.12 | -- | 55.19 | -25.69 | -25.69 | 2.40 | 36.20 | 0.0494 | 0.0538 | 1.82 | 5,525,137.00 | -51.01 | -50.16 | -52.60 | -53.46 | 99.26 | 97.56 | -1,033.29 | -1,068.36 | 30.81 | -180.53 | 0.00 | -- | 773.28 | 8.71 | 13.52 | -- | -74.64 | -- |
| Nippon Chemiphar Co Ltd | 32.52bn | 545.00m | 7.46bn | 855.00 | 11.59 | 0.3296 | 3.64 | 0.2293 | 151.00 | 151.00 | 9,009.80 | 5,309.46 | 0.6233 | 1.98 | 2.75 | 38,035,090.00 | 1.04 | 0.6794 | 1.44 | 0.9686 | 26.19 | 28.43 | 1.68 | 1.04 | 1.34 | -- | 0.4785 | 55.16 | 5.93 | 0.5075 | 263.33 | -7.58 | 32.85 | 0.00 |
| K Pharma Inc | 0.00 | -993.23m | 7.95bn | 17.00 | -- | 6.28 | -- | -- | -85.59 | -85.59 | 0.00 | 109.00 | 0.00 | 0.00 | -- | -- | -37.53 | -- | -38.74 | -- | -- | -- | -- | -- | 28.29 | -1,982.81 | 0.5424 | -- | -- | -- | -17.34 | -- | -- | -- |
| CellSource Co Ltd | 3.71bn | 10.66m | 8.13bn | 148.00 | 819.44 | 1.35 | 38.91 | 2.19 | 0.5003 | 0.5003 | 186.84 | 303.58 | 0.5265 | 5.91 | 11.31 | 25,077,400.00 | 0.1512 | 10.68 | 0.1613 | 11.89 | 56.24 | 64.88 | 0.2872 | 14.37 | 11.79 | 16.09 | 0.0093 | 20.88 | -14.78 | 14.87 | -95.52 | -47.76 | 8.90 | -- |
| COSMO BIO COMPANY, LIMITED | 10.51bn | 243.00m | 8.15bn | 174.00 | 31.62 | 0.8244 | 20.43 | 0.7755 | 42.64 | 42.64 | 1,842.53 | 1,635.05 | 0.891 | 6.52 | 4.02 | 60,419,540.00 | 2.08 | 5.38 | 2.41 | 6.41 | 34.20 | 36.39 | 2.34 | 5.95 | 5.52 | -- | 0.002 | 41.03 | 7.46 | 5.75 | -40.72 | 2.03 | 8.68 | 28.99 |
| Solasia Pharma KK | 326.00m | -1.80bn | 8.35bn | 23.00 | -- | 4.48 | -- | 25.60 | -8.12 | -8.12 | 1.44 | 6.91 | 0.1383 | 0.5431 | 5.67 | 14,173,910.00 | -76.18 | -64.46 | -87.38 | -80.79 | 73.93 | 59.35 | -550.92 | -401.81 | 4.27 | -77.04 | 0.0547 | -- | -48.78 | -24.75 | -74.55 | -- | -73.26 | -- |
| CellSeed Inc | 120.30m | -1.03bn | 11.16bn | 38.00 | -- | 7.98 | -- | 92.80 | -29.71 | -29.71 | 3.47 | 37.83 | 0.0562 | 1.22 | 4.75 | 3,165,816.00 | -48.11 | -45.50 | -51.99 | -49.29 | 52.72 | 57.47 | -856.11 | -478.14 | 7.05 | -- | 0.0949 | -- | 1.65 | -6.87 | -1.57 | -- | 6.39 | -- |
| Wakamoto Pharmaceutical Co Ltd | 9.29bn | 298.60m | 11.29bn | 286.00 | 37.66 | 0.93 | 15.24 | 1.21 | 8.60 | 8.60 | 267.77 | 348.39 | 0.6006 | 1.62 | 3.06 | 32,493,160.00 | 1.93 | -0.0678 | 2.22 | -0.0781 | 47.70 | 48.65 | 3.21 | -0.1246 | 2.42 | -- | 0.0082 | -- | 0.6595 | -6.53 | -40.86 | -- | 21.87 | -- |
Data as of Feb 13 2026. Currency figures normalised to Cosmo Bio Co Ltd's reporting currency: Japanese Yen JPY
